The following testimonials are the real-life accounts of 2 ELMIRON® patients. These patients discuss how they were diagnosed with and treated for IC and how treatment with ELMIRON® helped to relieve their IC symptoms.
Kristina Lee
Kristina had just gotten married and was about to finish college when urinary urgency and frequency began making her life miserable. She was diagnosed with IC and began taking ELMIRON® every day as directed. In less than 6 months, Kristina was feeling better.
Individual results may vary.
Randy Campbell
Randy's chronic pelvic pain made sitting for long periods of time difficult. After being misdiagnosed several times, he learned he had IC and was prescribed ELMIRON®. His improvement began soon thereafter, and he says he continues to feel good as long as he continues taking ELMIRON®.
Individual results may vary.
Important Safety Information
- Contraindications: ELMIRON® is contraindicated in patients with known hypersensitivity to the drug, structurally related compounds, or excipients
- Anticoagulant Activity: ELMIRON® is a weak anticoagulant (blood thinner) which may increase bleeding. Patients undergoing invasive surgery or having signs/symptoms of underlying coagulopathy or other increased risk of bleeding (due to anticoagulant therapy or high doses of anti-inflammatory drugs) should be evaluated for the risk of hemorrhage
- Alopecia: In clinical trials of ELMIRON®, alopecia began within the first 4 weeks of treatment. Ninety-seven percent (97%) of the cases of alopecia reported were alopecia areata, limited to a single area on the scalp
- Use in Pregnancy: ELMIRON® is a Pregnancy Category B drug
- Most Common Adverse Reactions (frequency 1% to 4%): Alopecia (4%), diarrhea (4%), nausea (4%), headache (3%), rash (3%), dyspepsia (2%), abdominal pain (2%), liver function abnormalities (1%), dizziness (1%)